Zhongzhu Medical Holdings Co Ltd (600568) - Net Assets

Latest as of September 2025: CN¥1.71 Billion CNY ≈ $250.64 Million USD

Based on the latest financial reports, Zhongzhu Medical Holdings Co Ltd (600568) has net assets worth CN¥1.71 Billion CNY (≈ $250.64 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.07 Billion ≈ $302.62 Million USD) and total liabilities (CN¥355.19 Million ≈ $51.98 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Zhongzhu Medical Holdings Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥1.71 Billion
% of Total Assets	82.82%
Annual Growth Rate	13.93%
5-Year Change	-56.21%
10-Year Change	-34.11%
Growth Volatility	87.23

Zhongzhu Medical Holdings Co Ltd - Net Assets Trend (1998–2024)

This chart illustrates how Zhongzhu Medical Holdings Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Zhongzhu Medical Holdings Co Ltd total assets for the complete picture of this company's asset base.

Annual Net Assets for Zhongzhu Medical Holdings Co Ltd (1998–2024)

The table below shows the annual net assets of Zhongzhu Medical Holdings Co Ltd from 1998 to 2024. For live valuation and market cap data, see Zhongzhu Medical Holdings Co Ltd stock valuation.

Year	Net Assets	Change
2024-12-31	CN¥1.74 Billion ≈ $255.02 Million	-32.72%
2023-12-31	CN¥2.59 Billion ≈ $379.07 Million	-11.79%
2022-12-31	CN¥2.94 Billion ≈ $429.73 Million	-21.24%
2021-12-31	CN¥3.73 Billion ≈ $545.62 Million	-6.31%
2020-12-31	CN¥3.98 Billion ≈ $582.38 Million	+2.26%
2019-12-31	CN¥3.89 Billion ≈ $569.54 Million	-8.57%
2018-12-31	CN¥4.26 Billion ≈ $622.92 Million	-30.74%
2017-12-31	CN¥6.15 Billion ≈ $899.41 Million	+2.23%
2016-12-31	CN¥6.01 Billion ≈ $879.82 Million	+127.31%
2015-12-31	CN¥2.65 Billion ≈ $387.06 Million	+2.54%
2014-12-31	CN¥2.58 Billion ≈ $377.47 Million	+118.82%
2013-12-31	CN¥1.18 Billion ≈ $172.51 Million	+14.70%
2012-12-31	CN¥1.03 Billion ≈ $150.39 Million	+12.22%
2011-12-31	CN¥915.88 Million ≈ $134.02 Million	+23.31%
2010-12-31	CN¥742.77 Million ≈ $108.69 Million	+9.67%
2009-12-31	CN¥677.27 Million ≈ $99.11 Million	+9.90%
2008-12-31	CN¥616.24 Million ≈ $90.17 Million	+19.66%
2007-12-31	CN¥514.98 Million ≈ $75.36 Million	+7.46%
2006-12-31	CN¥479.24 Million ≈ $70.13 Million	-14.23%
2005-12-31	CN¥558.76 Million ≈ $81.76 Million	+14.15%
2004-12-31	CN¥489.48 Million ≈ $71.63 Million	+3.50%
2003-12-31	CN¥472.91 Million ≈ $69.20 Million	+6.35%
2002-12-31	CN¥444.66 Million ≈ $65.07 Million	+2.58%
2001-12-31	CN¥433.47 Million ≈ $63.43 Million	+426.29%
2000-12-31	CN¥82.36 Million ≈ $12.05 Million	+18.07%
1999-12-31	CN¥69.76 Million ≈ $10.21 Million	+18.87%
1998-12-31	CN¥58.68 Million ≈ $8.59 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Zhongzhu Medical Holdings Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 24044.4% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	CN¥1.99 Billion	113.93%
Other Comprehensive Income	CN¥122.56 Million	7.01%
Other Components	CN¥2.90 Billion	165.72%
Total Equity	CN¥1.75 Billion	100.00%

Zhongzhu Medical Holdings Co Ltd Competitors by Market Cap

The table below lists competitors of Zhongzhu Medical Holdings Co Ltd ranked by their market capitalization.

Company	Market Cap
Jiangsu Flowers King SHG:603007	$772.83 Million
Aarti Pharmalabs Limited NSE:AARTIPHARM	$772.93 Million
Sunflag Iron And Steel Company Limited NSE:SUNFLAG	$773.07 Million
Zehnder SW:ZEHN	$773.11 Million
Pricol Limited NSE:PRICOLLTD	$772.28 Million
Grendene S.A SA:GRND3	$771.81 Million
Peakstone Realty Trust NYSE:PKST	$771.78 Million
Savencia SA PA:SAVE	$771.57 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Zhongzhu Medical Holdings Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 2,453,996,685 to 1,749,275,473, a change of -704,721,212 (-28.7%).
Net loss of 620,220,639 reduced equity.
Dividend payments of 324,381 reduced retained earnings.
Share repurchases of 89,999,961 reduced equity.
Other comprehensive income increased equity by 5,499,398.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥-620.22 Million	-35.46%
Dividends Paid	CN¥324.38K	-0.02%
Share Repurchases	CN¥90.00 Million	-5.14%
Other Comprehensive Income	CN¥5.50 Million	+0.31%
Other Changes	CN¥324.37K	+0.02%
Total Change	CN¥-	-28.72%

Book Value vs Market Value Analysis

This analysis compares Zhongzhu Medical Holdings Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.98x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 32.79x to 2.98x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1998-12-31	CN¥0.08	CN¥2.65	x
1999-12-31	CN¥0.10	CN¥2.65	x
2000-12-31	CN¥0.11	CN¥2.65	x
2001-12-31	CN¥0.60	CN¥2.65	x
2002-12-31	CN¥0.61	CN¥2.65	x
2003-12-31	CN¥0.63	CN¥2.65	x
2004-12-31	CN¥0.65	CN¥2.65	x
2005-12-31	CN¥0.61	CN¥2.65	x
2006-12-31	CN¥0.49	CN¥2.65	x
2007-12-31	CN¥0.49	CN¥2.65	x
2008-12-31	CN¥0.41	CN¥2.65	x
2009-12-31	CN¥0.63	CN¥2.65	x
2010-12-31	CN¥0.71	CN¥2.65	x
2011-12-31	CN¥0.89	CN¥2.65	x
2012-12-31	CN¥0.94	CN¥2.65	x
2013-12-31	CN¥1.00	CN¥2.65	x
2014-12-31	CN¥2.32	CN¥2.65	x
2015-12-31	CN¥1.72	CN¥2.65	x
2016-12-31	CN¥3.24	CN¥2.65	x
2017-12-31	CN¥3.01	CN¥2.65	x
2018-12-31	CN¥2.03	CN¥2.65	x
2019-12-31	CN¥1.90	CN¥2.65	x
2020-12-31	CN¥1.89	CN¥2.65	x
2021-12-31	CN¥1.80	CN¥2.65	x
2022-12-31	CN¥1.40	CN¥2.65	x
2023-12-31	CN¥1.23	CN¥2.65	x
2024-12-31	CN¥0.89	CN¥2.65	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Zhongzhu Medical Holdings Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -35.46%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -118.96%
• Asset Turnover: 0.25x
• Equity Multiplier: 1.21x
Recent ROE (-35.46%) is below the historical average (-0.88%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1998	16.29%	17.17%	0.53x	1.78x	CN¥3.69 Million
1999	15.88%	17.64%	0.55x	1.64x	CN¥4.10 Million
2000	15.31%	16.53%	0.57x	1.63x	CN¥4.37 Million
2001	3.20%	16.98%	0.18x	1.06x	CN¥-29.48 Million
2002	2.52%	12.33%	0.19x	1.08x	CN¥-33.28 Million
2003	2.53%	6.47%	0.31x	1.25x	CN¥-34.07 Million
2004	1.85%	1.94%	0.59x	1.63x	CN¥-38.62 Million
2005	-8.54%	-4.68%	0.59x	3.11x	CN¥-82.33 Million
2006	-24.30%	-5.85%	1.13x	3.67x	CN¥-122.27 Million
2007	5.01%	0.99%	1.40x	3.61x	CN¥-18.38 Million
2008	9.90%	1.65%	1.49x	4.01x	CN¥-422.47K
2009	22.78%	7.25%	1.41x	2.23x	CN¥82.22 Million
2010	10.12%	16.40%	0.21x	2.91x	CN¥877.83K
2011	20.07%	39.44%	0.22x	2.30x	CN¥91.86 Million
2012	6.22%	9.59%	0.28x	2.33x	CN¥-36.57 Million
2013	5.88%	7.67%	0.30x	2.56x	CN¥-42.42 Million
2014	1.36%	3.03%	0.24x	1.91x	CN¥-205.02 Million
2015	3.01%	7.96%	0.21x	1.76x	CN¥-170.34 Million
2016	5.02%	26.77%	0.15x	1.22x	CN¥-291.74 Million
2017	2.83%	17.26%	0.13x	1.21x	CN¥-429.55 Million
2018	-46.73%	-330.73%	0.10x	1.39x	CN¥-2.30 Billion
2019	-10.02%	-53.08%	0.15x	1.30x	CN¥-738.09 Million
2020	0.08%	0.44%	0.16x	1.19x	CN¥-376.39 Million
2021	-5.87%	-36.36%	0.13x	1.24x	CN¥-571.03 Million
2022	-28.57%	-157.97%	0.14x	1.33x	CN¥-1.08 Billion
2023	-14.02%	-53.86%	0.21x	1.23x	CN¥-589.34 Million
2024	-35.46%	-118.96%	0.25x	1.21x	CN¥-795.15 Million

Industry Comparison

This section compares Zhongzhu Medical Holdings Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $4,691,234,838
Average return on equity (ROE) among peers: 6.16%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Zhongzhu Medical Holdings Co Ltd (600568)	CN¥1.71 Billion	16.29%	0.21x	$772.79 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078)	$903.62 Million	4.28%	2.45x	$1.16 Billion
Anhui Fengyuan Pharmaceutical Co Ltd (000153)	$1.22 Billion	5.35%	1.27x	$441.99 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423)	$9.87 Billion	20.71%	0.25x	$5.01 Billion
Livzon Pharmaceutical Group Inc (000513)	$1.07 Billion	3.83%	0.46x	$2.80 Billion
Wedge Industrial Co Ltd (000534)	$1.15 Billion	11.42%	1.59x	$3.04 Billion
Yunnan Baiyao Group Co Ltd (000538)	$9.03 Billion	25.71%	0.43x	$13.75 Billion
Hainan Haiyao Co Ltd (000566)	$275.57 Million	17.28%	1.12x	$947.33 Million
Tus Pharmaceutical Group Co Ltd (000590)	$231.22 Million	-38.13%	1.23x	$389.67 Million
Northeast Pharmaceutical Group Co Ltd (000597)	$4.29 Billion	2.31%	2.07x	$1.03 Billion
Jilin Aodong Pharmaceutical Group Co Ltd (000623)	$18.87 Billion	8.83%	0.08x	$3.32 Billion

About Zhongzhu Medical Holdings Co Ltd

SHG:600568 China Drug Manufacturers - Specialty & Generic

Market Cap

$772.79 Million

CN¥5.28 Billion CNY

Market Cap Rank

#10401 Global

#3020 in China

Share Price

CN¥2.65

Change (1 day)

-0.38%

52-Week Range

CN¥1.34 - CN¥3.21

All Time High

CN¥9.91